HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Low-dose etoposide in a patient with adult T-cell leukemia/lymphoma who had severe complications].

Abstract
A 76-year-old female had been followed in our hospital for dissecting aneurysm, cardiac failure, and cerebral infarction. Inguinal lymphadenopathy, anorexia, and weight loss were noted in June 1998. The histopathologic diagnosis of the biopsied lymph node was diffuse pleomorphic type non-Hodgkin's lymphoma with T-cellular phenotype, and the patient was referred to our department. She had human T-lymphotropic virus type I seropositivity, and PCR of the pX lesion disclosed a monoclonal band. She was ultimately diagnosed as having adult T-cell leukemia/lymphoma (ATL/L, stage IV). Since she had many severe complications, she was given low-dose etoposide (LD-ETP, 50 mg/day). Atypical cells disappeared from the blood, and lymphadenopathy regressed. No major adverse reaction was observed after LD-ETP. She continued to receive intermittent LD-ETP, but she developed pneumonia in June 2000, and died in August 2000. Autopsy disclosed no residual lymphomatous lesions. These findings suggest that LD-ETP is a well tolerable and effective treatment in patients with ATL/L even if there are severe complications.
AuthorsF Xinjia, S Matano, S Amitani, S Terahata, H Furusyo, M Yamamoto, T Sugimoto
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 28 Issue 9 Pg. 1269-72 (Sep 2001) ISSN: 0385-0684 [Print] Japan
PMID11579638 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Etoposide
Topics
  • Aged
  • Aortic Dissection (complications)
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Aortic Aneurysm (complications)
  • Cerebral Infarction (complications)
  • Etoposide (administration & dosage)
  • Female
  • Heart Failure (complications)
  • Humans
  • Hypertension, Pulmonary (complications)
  • Leukemia-Lymphoma, Adult T-Cell (complications, drug therapy)
  • Pulmonary Embolism (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: